Corcept Therapeutics Incorporated
CORT
$115.70
$1.721.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 308.20M | 338.18M | 372.15M | 421.68M | 342.23M |
| Total Receivables | 76.92M | 39.07M | 59.79M | 69.63M | 64.57M |
| Inventory | 13.19M | 12.89M | 12.87M | 12.35M | 12.28M |
| Prepaid Expenses | 17.57M | 19.86M | 23.26M | 22.98M | 9.69M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 23.81M | 16.03M | 17.40M | 14.49M | 14.35M |
| Total Current Assets | 439.68M | 426.03M | 485.46M | 541.13M | 443.11M |
|
|
|||||
| Total Current Assets | 439.68M | 426.03M | 485.46M | 541.13M | 443.11M |
| Net Property, Plant & Equipment | 11.99M | 10.37M | 6.47M | 6.87M | 7.31M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 200.58M | 201.22M | 184.44M | 173.05M | 178.52M |
| Total Assets | 888.70M | 814.88M | 836.65M | 823.61M | 801.72M |
|
|
|||||
| Total Accounts Payable | 14.91M | 33.31M | 40.44M | 34.45M | 23.53M |
| Total Accrued Expenses | 122.22M | 102.11M | 117.64M | 125.86M | 113.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.92M | 1.63M | 1.08M | 1.05M | 1.02M |
| Total Finance Division Other Current Liabilities | 14.75M | 12.14M | 6.91M | 10.91M | 6.88M |
| Total Other Current Liabilities | 14.75M | 12.14M | 6.91M | 10.91M | 6.88M |
| Total Current Liabilities | 153.80M | 149.19M | 166.09M | 172.27M | 144.66M |
|
|
|||||
| Total Current Liabilities | 153.80M | 149.19M | 166.09M | 172.27M | 144.66M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.50M | 8.01M | 5.02M | 5.31M | 5.59M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 21.62M | 19.70M | 17.74M | 14.13M | 15.68M |
| Total Liabilities | 182.93M | 176.89M | 188.85M | 191.71M | 165.93M |
|
|
|||||
| Common Stock & APIC | 1.05B | 1.00B | 968.74M | 933.75M | 901.00M |
| Retained Earnings | 654.61M | 611.63M | 643.39M | 619.10M | 599.43M |
| Treasury Stock & Other | -997.58M | -975.77M | -964.32M | -920.95M | -864.64M |
| Total Common Equity | 705.78M | 637.99M | 647.81M | 631.90M | 635.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 705.78M | 637.99M | 647.81M | 631.90M | 635.79M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 705.78M | 637.99M | 647.81M | 631.90M | 635.79M |
|
|
|||||